Specialty CompassAustralian specialty training guide
Home / Specialties / Haematology

Haematology

RACP. Blood cancers, clotting and the lab, a joint clinical/laboratory specialty (RACP + RCPA) with transplant and CAR-T at its tertiary end.

Medicine (physician)4 years AT typical (joint clinical + laboratory FRACP/FRCPA)Competitiveness: highSubspecialty, entry via Basic Physician Training (Adult Medicine)
Competition snapshot: High   Contested at transplant centres; joint-program places limited (indicative)
Program length
4 years AT typical (joint clinical + laboratory FRACP/FRCPA)
Typical entry
AT from PGY5–6
Women (trainees)
≈ 55% of trainees
Consultant (public)
$300,000–470,000 package
Consultant (private)
$350,000–600,000 (private lab roles add) (indicative)
Hours & lifestyle
Febrile neutropenia call; lab years gentler
Entry routeYou enter Haematology through Basic Physician Training (Adult Medicine): complete basic training and both divisional exams first, then compete for advanced-training posts in this specialty. This page covers what's specific to Haematology.

Overview

Haematology uniquely spans the bedside and the bench: you treat leukaemia, lymphoma, myeloma and clotting disorders, and you also report the films, run the lab and control transfusion. Most Australian trainees complete the joint RACP/RCPA program (about four years) and exit with both fellowships, a combination that makes haematologists structurally employable.

Selection and points

How selection works

ComponentWhat it involves
AT job application (joint program posts)Hospital/lab-level selection; the RCPA side adds lab rotations and Part exams.
The unofficial view
  • Transfusion or malignant-haem research plus reliability on the ward haem term is the entry signal; the joint program's lab exams deserve respect; plan study years.

Competition & demographics

Competitiveness

  • Moderately competitive; transplant/CAR-T centres most contested.

Who's in the program

  • Majority-female trainee cohort.

How to improve your chances at each stage

StageResident (PGY2–3)
  • Haem BPT terms; learn film morphology early; it marks you as serious.
StageRegistrar years & applications
  • Choose joint-program sites with strong lab teaching; a myeloma/lymphoma project travels well.
StageIf you don't get on (or change your mind)
  • Adjacent: medical oncology, general pathology (haem-lean), transfusion medicine.

See also the general strategy guide: universal CV, referee and interview advice that applies across specialties.

Job market & workforce outlook

Outlook: Strong, myeloma/lymphoma therapeutics exploding, pathology-side shortage helps employability
  • Public demand solid; private laboratory haematology chronically short; regional centres need clinical haematologists.

Income

  • $350,000–600,000 indicative across clinical/lab mixes.

Pre-tax, indicative, and highly variable with hours, setting and billing model. ATO figures are averages of taxable income by reported occupation.

Subspecialties & special interests

AreaNotes
BMT/CAR-TQuaternary
Malignant haemMyeloma/lymphoma therapeutics
Thrombosis/haemostasisConsult service core
TransfusionLab leadership

Community: questions and perspectives

CommunityAsk questions and share real-world experience below. Sign in with your email (button top right) to post. Your training stage and specialty interest appear beside your name so readers know the perspective, and the best posts are folded into the page at each annual review.

❓ Questions & answers

Loading…

🩺 Experiences, corrections & perspectives

If you've trained in haematology, or tried to, share what the page can't capture: what it's really like, what's changed, what you wish you'd known.

Loading…

Last reviewed July 2026. Details marked “verified” were checked against official/current sources at review; unmarked figures are indicative estimates from training data, college publications and community knowledge. Selection regulations change annually, always read the current-year official documents before acting.
↑